BROOKE CARR: Open Payments
NPI 1699242347 · TEXARKANA, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$729 in 36 payments from 10 companies in 2025. Trend: 2023 $1,056 · 2024 $691 · 2025 $729
Food & beverage: $620Education: $110
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $156 |
| Novartis Pharmaceuticals Corporation | 7 | $136 |
| Janssen Biotech, Inc. | 1 | $100 |
| Organon LLC | 5 | $82 |
| Abbott Laboratories | 4 | $82 |
| Lilly USA, LLC | 3 | $67 |
| PFIZER INC. | 2 | $44 |
| GENZYME CORPORATION | 1 | $26 |
| UCB, Inc. | 1 | $20 |
| Galderma Laboratories, L.P. | 1 | $15 |
Products named: TREMFYA, SKYRIZI, RINVOQ, TALTZ, CARDIOMEMS, VTAMA, CIBINQO, FREESTYLE LIBRE 3.
Industry payments across TX — which companies pay providers there.
